Eli Gilboa

25.2k citations
181 papers · 21.8k · 5 hit papers · h-index 80

Impact in

  • Immunology top 0.05%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Virology top 0.5%

Papers in

    • Immunotherapy and Immune Responses 92
    • Immune Cell Function and Interaction 26
    • T-cell and B-cell Immunology 20
    • Virus-based gene therapy research 52

Eli Gilboa

180 papers receiving 20.4k citations

Eli Gilboa's Hit Papers

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras 2006 · 877 citations
8770+15+31Years since publication250500750

Peers

Eli Gilboa
Comparison fields: 5 of 136
  • Immunology 10.9k
  • Virology 1.3k
  • Oncology 6.2k
  • Genetics 5.1k
  • Molecular Biology 11.8k
Replace Philip D. Greenberg with:
Philip D. Greenberg United States
James L. Riley United States
Michael S. Neuberger United Kingdom
Cornelis J.M. Melief Netherlands
Donald B. Kohn United States
Peter M. Howley United States
A.J. van der Eb Netherlands
John Cameron Bell Canada
Peter Van Endert France
Sjoerd H. van der Burg Netherlands
Eli Gilboa relative to Philip D. Greenberg United States Philip D. Greenberg's profile →
Citations per field
00.5×1.5×2.1×
Philip D. Greenberg · 1×
Citations per year

Countries citing papers authored by Eli Gilboa

Since Specialization
Citations

This map shows the geographic impact of Eli Gilboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Gilboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Gilboa more than expected).

Fields of papers citing papers by Eli Gilboa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Gilboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Gilboa. The network helps show where Eli Gilboa may publish in the future.

Co-authors

The 25 scholars most cited alongside Eli Gilboa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eli Gilboa Line = papers co-authored together Eli Gilboa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
Hit paper breakdown →
2006877
2
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Hit paper breakdown →
1996814
3
A detailed model of reverse transcription and tests of crucial aspects
Hit paper breakdown →
1979559
4 1990545
5
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors
Hit paper breakdown →
1985518
6 2007484
7 1986448
8 2002434
9
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA
Hit paper breakdown →
1980428
10 2002406
11 1990383
12 1997381
13 2014378
14
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.
1990361
15 2012358
16 1998349
17 1995339
18 1987326
19 1999324
20 2018324

About Eli Gilboa

Eli Gilboa is a scholar working on Immunology, Genetics, Oncology, Molecular Biology and Virology, having authored 181 papers that have together received 21.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (92 papers), RNA Interference and Gene Delivery (60 papers), Virus-based gene therapy research (52 papers), CAR-T cell therapy research (26 papers), Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (20 papers), CRISPR and Genetic Engineering (18 papers) and Advanced biosensing and bioanalysis techniques (17 papers). The work is most often cited by research in Immunology (10.9k citations), Virology (1.3k citations), Oncology (6.2k citations), Genetics (5.1k citations) and Molecular Biology (11.8k citations). Eli Gilboa has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Smita K. Nair, David Boczkowski, Bruce A. Sullenger, Johannes Vieweg, David J. Snyder, David Baltimore, Angel Porgador, Herbert Kim Lyerly, Rajat Bannerji and Stephen P. Goff. Their work appears in journals such as The Journal of Immunology, Blood, Journal of Virology, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact